Evidence map›Paper›PMID 36910273›Full record

ArticleMaterials today. Bio2023

3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular

Ramin Nasehi, Ali T Abdallah, Marcella Pantile, Carlo Zanon, Michael Vogt, Stephan Rütten, Horst Fischer, Sanja Aveic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ramin NasehiDepartment of Dental Materials and Biomaterials Research, RWTH Aachen University Hospital, 52074, Aachen, Germany.
Ali T AbdallahInterdisciplinary Center for Clinical Research, RWTH Aachen University Hospital, 52074, Aachen, Germany.
Marcella PantileTarget Discovery and Biology of Neuroblastoma, Istituto di Ricerca Pediatrica Fondazione Città Della Speranza, 35127, Padova, Italy.
Carlo ZanonBioinformatics Core Facility, Istituto di Ricerca Pediatrica Fondazione Città Della Speranza, 35127, Padova, Italy.
Michael VogtInterdisciplinary Center for Clinical Research, RWTH Aachen University Hospital, 52074, Aachen, Germany.
Stephan RüttenElectron Microscopy Facility, Institute of Pathology, RWTH Aachen University Hospital, 52074, Aachen, Germany.
Horst FischerDepartment of Dental Materials and Biomaterials Research, RWTH Aachen University Hospital, 52074, Aachen, Germany.
Sanja AveicDepartment of Dental Materials and Biomaterials Research, RWTH Aachen University Hospital, 52074, Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key challenge for the discovery of novel molecular targets and therapeutics against pediatric bone metastatic disease is the lack of bona fide

Indexed as

3D bioengineeringIn vitro biological modelsMetastatic bone modelTumor microenvironmentβ-TCP ceramics Application

Identifiers

PMID36910273
PMCPMC9999213

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.